Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept

Chloroquine and hydroxychloroquine have been proposed recently as therapy for SARS-CoV-2-infected patients, but during 3 months of extensive use concerns were raised related to their clinical effectiveness and arrhythmogenic risk. Therefore, we estimated for these compounds several proarrhythmogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomet, Urs, Amuzescu, Bogdan, Knott, Thomas, Mann, Stefan A., Mubagwa, Kanigula, Radu, Beatrice Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590616/
https://www.ncbi.nlm.nih.gov/pubmed/34785211
http://dx.doi.org/10.1016/j.ejphar.2021.174632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590616/
https://www.ncbi.nlm.nih.gov/pubmed/34785211
http://dx.doi.org/10.1016/j.ejphar.2021.174632

Ejemplares similares